Completed PHASE1/PHASE2 INTERVENTIONAL NCT00079807

Painful HIV Neuropathy and Alpha-Lipoic Acid

Painful HIV Neuropathy: Treatment With Alpha-Lipoic Acid

Sponsor: National Center for Complementary and Integrative Health (NCCIH)

Updated 5 times since 2017 Last updated: Apr 21, 2008 Started: Sep 30, 2003 Primary completion: Feb 28, 2007 Completion: Feb 28, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on HIV and Peripheral Neuropathy, this trial is completed. The trial is conducted by National Center for Complementary and Integrative Health (NCCIH) and has accumulated 5 data snapshots since 2003. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Complementary and Integrative Health (NCCIH)

Data source: National Center for Complementary and Integrative Health (NCCIH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chapel Hill, United States